These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10514485)

  • 1. Prenylated prelamin A interacts with Narf, a novel nuclear protein.
    Barton RM; Worman HJ
    J Biol Chem; 1999 Oct; 274(42):30008-18. PubMed ID: 10514485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirements for efficient proteolytic cleavage of prelamin A by ZMPSTE24.
    Barrowman J; Hamblet C; Kane MS; Michaelis S
    PLoS One; 2012; 7(2):e32120. PubMed ID: 22355414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleoplasmic localization of prelamin A: implications for prenylation-dependent lamin A assembly into the nuclear lamina.
    Lutz RJ; Trujillo MA; Denham KS; Wenger L; Sinensky M
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):3000-4. PubMed ID: 1557405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prelamin A endoproteolytic processing in vitro by recombinant Zmpste24.
    Corrigan DP; Kuszczak D; Rusinol AE; Thewke DP; Hrycyna CA; Michaelis S; Sinensky MS
    Biochem J; 2005 Apr; 387(Pt 1):129-38. PubMed ID: 15479156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome.
    Mallampalli MP; Huyer G; Bendale P; Gelb MH; Michaelis S
    Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14416-21. PubMed ID: 16186497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laminopathy-inducing mutations reduce nuclear import of expressed prelamin A.
    Kiel T; Busch A; Meyer-Rachner A; Hübner S
    Int J Biochem Cell Biol; 2014 Aug; 53():271-80. PubMed ID: 24943589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro assay and characterization of the farnesylation-dependent prelamin A endoprotease.
    Kilic F; Dalton MB; Burrell SK; Mayer JP; Patterson SD; Sinensky M
    J Biol Chem; 1997 Feb; 272(8):5298-304. PubMed ID: 9030603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An accumulation of non-farnesylated prelamin A causes cardiomyopathy but not progeria.
    Davies BS; Barnes RH; Tu Y; Ren S; Andres DA; Spielmann HP; Lammerding J; Wang Y; Young SG; Fong LG
    Hum Mol Genet; 2010 Jul; 19(13):2682-94. PubMed ID: 20421363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The processing pathway of prelamin A.
    Sinensky M; Fantle K; Trujillo M; McLain T; Kupfer A; Dalton M
    J Cell Sci; 1994 Jan; 107 ( Pt 1)():61-7. PubMed ID: 8175923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An antibody which specifically recognizes prelamin A but not mature lamin A: application to detection of blocks in farnesylation-dependent protein processing.
    Sinensky M; Fantle K; Dalton M
    Cancer Res; 1994 Jun; 54(12):3229-32. PubMed ID: 8205544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of prelamin A biogenesis reveals the nucleus to be a CaaX processing compartment.
    Barrowman J; Hamblet C; George CM; Michaelis S
    Mol Biol Cell; 2008 Dec; 19(12):5398-408. PubMed ID: 18923140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prelamin A, Zmpste24, misshapen cell nuclei, and progeria--new evidence suggesting that protein farnesylation could be important for disease pathogenesis.
    Young SG; Fong LG; Michaelis S
    J Lipid Res; 2005 Dec; 46(12):2531-58. PubMed ID: 16207929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerin-prelamin A interplay in human fibroblasts.
    Capanni C; Del Coco R; Mattioli E; Camozzi D; Columbaro M; Schena E; Merlini L; Squarzoni S; Maraldi NM; Lattanzi G
    Biol Cell; 2009 Sep; 101(9):541-54. PubMed ID: 19323649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prelamin A farnesylation and progeroid syndromes.
    Young SG; Meta M; Yang SH; Fong LG
    J Biol Chem; 2006 Dec; 281(52):39741-5. PubMed ID: 17090536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs affecting prelamin A processing: effects on heterochromatin organization.
    Mattioli E; Columbaro M; Capanni C; Santi S; Maraldi NM; D'Apice MR; Novelli G; Riccio M; Squarzoni S; Foisner R; Lattanzi G
    Exp Cell Res; 2008 Feb; 314(3):453-62. PubMed ID: 18093584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the purpose of prelamin A processing.
    Davies BS; Coffinier C; Yang SH; Barnes RH; Jung HJ; Young SG; Fong LG
    Nucleus; 2011; 2(1):4-9. PubMed ID: 21647293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcellular localization and partial purification of prelamin A endoprotease: an enzyme which catalyzes the conversion of farnesylated prelamin A to mature lamin A.
    Kilic F; Johnson DA; Sinensky M
    FEBS Lett; 1999 Apr; 450(1-2):61-5. PubMed ID: 10350058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagic Removal of Farnesylated Carboxy-Terminal Lamin Peptides.
    Lu X; Djabali K
    Cells; 2018 Apr; 7(4):. PubMed ID: 29690642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mislocalization of prelamin A Tyr646Phe mutant to the nuclear pore complex in human embryonic kidney 293 cells.
    Pan Y; Garg A; Agarwal AK
    Biochem Biophys Res Commun; 2007 Mar; 355(1):78-84. PubMed ID: 17291448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different prelamin A forms accumulate in human fibroblasts: a study in experimental models and progeria.
    Dominici S; Fiori V; Magnani M; Schena E; Capanni C; Camozzi D; D'Apice MR; Le Dour C; Auclair M; Caron M; Novelli G; Vigouroux C; Maraldi NM; Lattanzi G
    Eur J Histochem; 2009; 53(1):43-52. PubMed ID: 19351612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.